risperidone has been researched along with 22q11.2 Deletion Syndrome in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study thus indicates that the interacting effects within the COMT gene polymorphisms may influence the disease status and response to risperidone in schizophrenia patients." | 3.75 | Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment. ( Baghel, R; Bhasin, Y; Bhatnagar, P; Brahmachari, SK; Chauhan, C; Grover, S; Gupta, M; Jain, S; Kaur, H; Kukreti, R; Manduva, V; Mukherjee, O; Purushottam, M; Sharma, A; Verma, B, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, M | 1 |
| Bhatnagar, P | 1 |
| Grover, S | 1 |
| Kaur, H | 1 |
| Baghel, R | 1 |
| Bhasin, Y | 1 |
| Chauhan, C | 1 |
| Verma, B | 1 |
| Manduva, V | 1 |
| Mukherjee, O | 1 |
| Purushottam, M | 1 |
| Sharma, A | 1 |
| Jain, S | 1 |
| Brahmachari, SK | 1 |
| Kukreti, R | 1 |
1 other study available for risperidone and 22q11.2 Deletion Syndrome
| Article | Year |
|---|---|
Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Case-Control Studies; Catechol O-Methyltransferase; Cognition Disorders | 2009 |